Controlled delivery of a hydrophilic drug from a biodegradable microsphere system by supercritical anti-solvent precipitation technique

J Microencapsul. 2006 Nov;23(7):741-9. doi: 10.1080/09687860600945552.

Abstract

The purpose of this study was to prepare microspheres loaded with hydrophilic drug, bupivacaine HCl using poly(D,L-lactic-co-glycolic acid) (PLGA) and poly(L-lactic acid) (PLLA). Microspheres were prepared with varying the PLGA/PLLA ratio with two different levels of bupivacaine HCl (5 and 10%) using a supercritical anti-solvent (SAS) technique. Microspheres ranging from 4-10 microm in geometric mean diameter could be prepared, with high loading efficiency. Powder X-ray diffraction (PXRD) revealed that bupivacaine HCl retained its crystalline state within the polymer and was present as a dispersion within the polymer phase after SAS processing. The release of bupivacaine HCl from biodegradable polymer microspheres was rapid up to 4 h, thereafter bupivacaine HCl was continuously and slowly released for at least 7 days according to the PLGA/PLLA ratio and the molecular weight of PLLA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Absorbable Implants
  • Biocompatible Materials / chemistry
  • Bupivacaine / administration & dosage*
  • Chemical Precipitation
  • Delayed-Action Preparations / administration & dosage
  • Drug Compounding / methods
  • Hydrochloric Acid / chemistry
  • Lactic Acid / chemistry
  • Microscopy, Electron, Scanning
  • Microspheres*
  • Particle Size
  • Polyesters
  • Polyglycolic Acid / chemistry
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Polymers / chemistry
  • Solvents / chemistry
  • Surface Properties
  • X-Ray Diffraction

Substances

  • Biocompatible Materials
  • Delayed-Action Preparations
  • Polyesters
  • Polymers
  • Solvents
  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Polyglycolic Acid
  • Lactic Acid
  • poly(lactide)
  • Hydrochloric Acid
  • Bupivacaine